Health Conditions

PHENYLALKYLAMINE: Verapamil Drug Study and Nursing Interventions

PHENYLALKYLAMINE: VERAPAMIL

GENERAL DESCRIPTION

Verapamil is the first clinically available Calcium channel blocker. It is it is an alkaloid vasodilator. Verapamil is less potent calcium channel blocker than amlodipine but more potent than diltiazem.

GENERIC NAME: Verapamil

BRAND NAME Calan, Isoptin, Verelan

MECHANISM OF ACTION

Cardiovascular response of verapamil is shown in following steps

Firstly, verapamil decrease myocardial contractile force which reduces myocardial oxygen requirements. Secondly, verapamil inhibits calcium influx into arterial smooth muscles resulted in decreased arteriolar tone and systemic vascular resistance. This process decreased the arterial and intraventricular pressure. As a result of all these steps, left ventricular wall stress decline and which reduces myocardial oxygen requirements. SA nodes and AV nodes, which are mainly composed of calcium channels are markedly effected by verapamil thus decreases atrioventricular nodal conduction and is effective medicine in supraventricular tachycardia and also decreasing ventricular responses in atrial fibrillation or flutter.

Cardiovascular effects of Verapamil

PHARMACOKINETICS

Verapamil is given orally and also intravenous route. The oral bioavailability of verapamil is 20-35% and plasma half-life is 6 hours. Verapamil absorption from the gut is reduced by p-glycoprotein. Verapamil is metabolized by CYP3A4 enzyme or cytochrome P450 system.

INDICATIONS

CONTRAINDICATIONS

SIDE EFFECTS & ADVERSE EFFECTS

DRUG INTERACTION

NURSING INTERVENTION

PATIENT EDUCATION

Exit mobile version